🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in individuals administering products of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Response and Material Removal

Based on TikTok, the platform has taken down problematic material and banned related keywords and query recommendations. The company said it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at residence.

After moments of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, messages display black plastic parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant medical dangers”.